NaviFUS' core technologies include the development of a Neuronavigation-Guided Focused Ultrasound (FUS) System for brain diseases. This innovative technology can temporarily open the blood-brain barrier (BBB) or regulate overactive neurons through neuromodulation, making it a promising treatment option for a range of neurological disorders.
NaviFUS is a Biotech company dedicated to providing novel platform solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. Our product, the NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. Our vision is to benefit CNS disease patients locally and globally by bringing breakthrough therapeutic ultrasound technology to clinical use through partnerships with global pharmaceutical companies.
GLUT Targeting Small Molecule Drug Conjugation for Cancer Therapy
Artificial Intelligence Acute Kidney Injury Prediction: Real-time Inference and Interactive Critical Care System
Integration of intelligent transcranial magnetic stimulation and language -cognitive VR training system
Multi-angle and lifelike manipulation in cardiac ultrasound.
Technology maturity：Others
Exhibiting purpose：Display of scientific results
Trading preferences：Negotiate by self、New products development
Coming soon!